Candel Therapeutics stockholders elect three Class III directors and ratify KPMG as auditor

Candel Therapeutics, Inc.

Nicoletta Loggia (7.18M for), Christopher Martell (6.99M for), Diem Nguyen (7.02M for) elected as Class III directors.
KPMG LLP ratified as independent auditor for fiscal 2024 with 14.62M for, 98.9K against, 42.9K abstain.
Meeting held June 26, 2024; record date May 15, 2024; 29.76M shares outstanding.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.